Skip to main content
. 2021 Nov 22;15(1):101272. doi: 10.1016/j.tranon.2021.101272

Fig. 6.

Fig. 6

BX-795 inhibits AKT pathway. (A) Gene expression analysis of PDK1, AKT1, MTOR, TBK1, and MYCN in response to BX-795 treatments in SH-SY5Y cells. (B) Western blot analysis of different AKT pathway proteins in response to increasing concentrations of BX-795 treatments. CyPB is used as loading control. * p < 0.05; ** p < 0.01.